Fig. 2From: Effects of novel androgen receptor signaling inhibitors on PSMA PET signal intensity in patients with castrate-resistant prostate cancer: a prospective exploratory serial imaging study68Ga-PSMA-11 PET maximum-intensity projection (MIP) of all patients at different time points with delineated lesions on qPSMA highlighted in red. Patient #02 underwent RT on metastatic bone lesions after PET 2 and died after visit #3. Serum PSA levels and PET metrics should be interpreted in light of the palliative RT. Patient #05 died for non-PCa related causes 9 months after initiation of ARSiBack to article page